HIF-1\#945; is required for both progestin-induced VEGF secretion by breast cancer cells and in vivo progression of progestin-dependent mammary tumors

被引：0
|
作者：
Carroll, Candace [1 ]
Benakanakere, Indira [1 ]
Besch-Williford, Cynthia [1 ]
Liang, Yayun [1 ]
Hyder, Salman [1 ]
机构：
[1] Univ Missouri, Columbia, MO USA
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4069
引用
收藏
页数：1
相关论文
共 14 条
  • [1] p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells
    Liang, YY
    Wu, JB
    Stancel, GM
    Hyder, SM
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2005, 93 (2-5): : 173 - 182
  • [2] The Nutraceutical Luteolin Inhibits Progestin-Dependent VEGF Induction in Breast Cancer Cells and Blocks Tumor Progression in a Xenograft Model
    Cook, Matthew T.
    Liang, Yayun
    Mafuvadze, Benford
    Besch-Williford, Cynthia
    Hyder, Salman M.
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [3] Apigenin Inhibits Progestin-Induced VEGF at Both mRNA and Protein Secretion Level in T47-D Human Breast Cancer Cells.
    Mafuvadze, B.
    Benakanakere, I.
    Hyder, S. M.
    ENDOCRINE REVIEWS, 2010, 31 (03)
  • [4] Progestin-induced mammary adenocarcinomas in BALB/c mice. Progression from hormone-dependent to autonomous tumors
    Lanari, C
    Montecchia, MF
    Pazos, P
    Simian, M
    Vanzulli, S
    Lamb, C
    Molinolo, AA
    MEDICINA-BUENOS AIRES, 1997, 57 : 55 - 69
  • [5] Luteolin inhibits progestin-dependent VEGF induction, stem-cell like characteristics, and tumor progression of human breast cancer cells
    Hyder, S. M.
    Cook, M. T.
    Besch-Williford, C.
    Liang, Y.
    CANCER RESEARCH, 2016, 76
  • [6] Progestin-induced caveolin-1 expression mediates proliferation of breast cancer cells
    Salatino, Mariana
    Beguelin, Wendy
    Proietti, Cecilia J.
    Carnevale, Romina
    Rosemblit, Cinthia
    Rivas, Martin
    Schillaci, Roxana
    Charreau, Eduardo H.
    Elizalde, Patricia V.
    CANCER RESEARCH, 2006, 66 (08)
  • [7] PGRMC1 Promotes Progestin-Dependent Proliferation of Breast Cancer Cells by Binding Prohibitins Resulting in Activation of ERα Signaling
    Bai, Yingxue
    Ludescher, Marina
    Poschmann, Gereon
    Stuehler, Kai
    Wyrich, Martine
    Oles, Julia
    Franken, Andre
    Rivandi, Mahdi
    Abramova, Anna
    Reinhardt, Florian
    Ruckhaeberle, Eugen
    Niederacher, Dieter
    Fehm, Tanja
    Cahill, Michael A.
    Stamm, Nadia
    Neubauer, Hans
    CANCERS, 2021, 13 (22)
  • [8] Enrichment of CD44high stem-cell-like cells as a possible mechanism of progestin-dependent progression of human breast cancer
    Goyette, Sandy
    Mafuvadze, Benford
    Cook, Matthew T.
    Liang, Yayun
    Ryder, Salman M.
    CANCER RESEARCH, 2015, 75
  • [9] Therapeutic effects of luteolin against progestin-dependent breast cancer involves induction of apoptosis, and suppression of both stem-cell-like cells and angiogenesis
    Cook, Matthew Thomas
    Liang, Yayun
    Goyette, Sandy
    Mafuvadze, Benford
    Besch-Williford, Cynthia
    Hyder, Salman
    CANCER RESEARCH, 2015, 75
  • [10] Salinomycin inhibits breast cancer progression via targeting HIF-1α/VEGF mediated tumor angiogenesis in vitro and in vivo
    Dewangan, Jayant
    Srivastava, Sonal
    Mishra, Sakshi
    Divakar, Aman
    Kumar, Sadan
    Rath, Srikanta Kumar
    BIOCHEMICAL PHARMACOLOGY, 2019, 164 : 326 - 335
12